key: cord-0695791-rwevmwcr
authors: Al-Matary, Abdulrahman; Almatari, Faeza; Al-Matary, Mariam; AlDhaefi, Alaa; Alqahtani, Mohammed Hassan S.; Alhulaimi, Emad Ahmad; AlOtaiby, Shahed; Almehiny, Khowlah; John, Lincy Soosan; Alanazi, Faisal Samah; Azad, Aisha; Aldandan, Faisal K.
title: Clinical outcomes of maternal and neonate with COVID-19 infection–Multicentre study in Saudi Arabia
date: 2021-04-20
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2021.03.013
sha: 9517ddb525370321f3b23ffb1632b0961ec57120
doc_id: 695791
cord_uid: rwevmwcr

Background To this end, the influence of COVID-19 on pregnant women and their neonates is not completely clear. Therefore, the main aim of this study is to investigate maternal and neonatal clinical outcomes with confirmed COVID-19 infection. Besides, it investigates the likelihood of vertical transmission of COVID-19 infection from pregnant women to their neonates. Methods A retrospective descriptive study was conducted in three medical centers during the period from March to November 2020. Data were collected from the available medical records in the respective hospitals using a standardized questionnaire on maternal and neonatal clinical outcomes. All pregnant women with confirmed COVID-19 infection across the three hospitals and their neonates were eligible to participate in this study. Descriptive statistics were presented as a median and interquartile range (IQR) or frequencies and percentages as appropriate using SPSS 24.0 software. Results This study has identified a total of 288 pregnant women with confirmed COVID-19 infection over the study period of a median age of 30 years and median GA at diagnosis 38 weeks (IQR: 39 -33) as well as 27% of them were obese (n=78). The majority of pregnant women were symptomatic with cough (n=92, 31.9%) being the most frequent COVID-19 symptom followed by fever and dyspnea (n=36, 12.5%). Two-hundred and four pregnant delivered (70.84%) and caesarean sections were prevalent among 35.8% of them. The most common adverse pregnancy outcome was premature (n=31, 15.5%), followed by fetal distress (n=13, 6.5%), preeclampsia (n=4, 2.0%), and one pregnant woman died. The laboratory results exhibit that temperature higher than 38 (n=27), leukopenia (n=19), neutropenia (n=54), ALT (n=12), AST (n=31), and thrombocytopenia (n=35) were less frequent among pregnant women while lymphopenia (n=126), hemoglobin levels lower than 13.0 (n=218), deceased albumin levels (n=195) were most frequent among them. However, a small proportion of pregnant women were admitted to the ICU (3.8%). The most frequent maternal treatments were antibiotics (n=81), antiviral (n=49), and corticosteroid (n=24). Of 204 neonates, four had died and all the remaining neonates were alive. The median gestational age at delivery was 39 weeks (IQR: 35–40). Most neonates had normal laboratory results. However, 14 had lymphopenia (7.0%), 22 had neutropenia (11.0%), and 11 had thrombocytopenia (5.5%). Four infants had low hemoglobin levels of less than 13.0 (2.0%) and 81 had hyperbilirubinemia (e.g., total bilirubin of higher than 23; 40.5%). Approximately less than one-half of neonates required admission to the NICU (n=86, 43%), 7% of them required respiratory support of mechanical ventilation, and none of them get infected with COVID-19 disease. Conclusion This multicenter study suggests that the majority of pregnant women had mild or moderate disease symptoms. Nevertheless, this study did not find any evidence of possible vertical transmission of COVID-19 infection from mothers to their babies. This study may provide a baseline for further studies focusing on investigating long-term maternal and neonate's outcomes and possible vertical transmission of COVID-19 from mothers to their newborn babies.

The majority of pregnant women were symptomatic with cough (n = 92, 31.9%) being the most frequent COVID-19 symptom followed by fever and dyspnea (n = 36, 12.5%). Two-hundred and four pregnant delivered (70.84%) and caesarean sections were prevalent among 35.8% of them. The most common adverse pregnancy outcome was premature (n= 31, 15.5%), followed by fetal distress (n = 13, 6.5%), preeclampsia (n = 4, 2.0%), and one pregnant woman died. The laboratory results exhibit that temperature higher than 38 (n= 27), leukopenia (n = 19) , neutropenia (n = 54), ALT (n = 12), AST (n=31), and thrombocytopenia (n = 35) were less frequent among pregnant women while lymphopenia (n = 126), hemoglobin levels lower than 13.0 (n = 218), deceased albumin levels (n = 195) were most frequent among them. However, a small proportion of pregnant women were admitted to the ICU (3.8%). The most frequent maternal treatments were antibiotics (n = 81), antiviral (n = 49), and corticosteroid (n = 24). Of 204 neonates, four had died and all the remaining neonates were alive. The median gestational age at delivery was 39 weeks (IQR: 35 -40) . Most neonates had normal laboratory results. However, 14 had lymphopenia (7.0%), 22 had neutropenia (11.0%), and 11 had thrombocytopenia (5.5%). Four infants had low hemoglobin levels of less than 13.0 (2.0%) and 81 had hyperbilirubinemia (e.g., total bilirubin of higher than 23; 40.5%). Approximately less than one-half of neonates required admission to the NICU (n= 86, 43%), 7% of them required respiratory support of mechanical ventilation, and none of them get infected with COVID-19 disease.

The viral respiratory infection associated with the novel coronavirus disease (COVID- 19 ) that was firstly emerged in Wuhan in China in December 2019 has spread out rapidly among people worldwide. This disease caused a global health crisis and it has been confirmed as a pandemic and as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) [1] [2] [3] . Positive confirmed cases mostly develop symptoms including fever, dry cough, headache, and fatigue or tiredness, loss of smell, and taste. In severe cases, patients may develop loss of breath, confusion, loss of appetite, and pneumonia [4] .

Pregnant women are being considered at a high risk of getting viral respiratory infections and having symptomatic of severe pneumonia because of the changes in J o u r n a l P r e -p r o o f their physiological characteristics including immune and cardiopulmonary systems that arise during pregnancy [5 -6] . The earlier viral infectious diseases such as the Middle East respiratory syndrome coronavirus (MERS) and the Severe Acute Respiratory Syndrome coronavirus (SARS), and influenza suggest that pregnant women are particularly susceptible to adverse outcomes such as admission to an intensive care unit (ICU) and death [7 -9] .

There is a growing debate regarding the clinical outcomes of maternal and neonates with confirmed COVID-19 [10 -41] . The study of Chen et al. was among the first exploratory studies that assessed the clinical outcomes and possibility of vertical transmission to their neonates among nine pregnant with COVID-19 disease in Wuhan [10] . Various studies have shown that most pregnant women have mild to moderate COVID-19 symptoms while a small proportion of them have developed severe symptoms including high temperature and pneumonia. However, almost all previous studies did not detect any possible vertical transmission to the neonates. A recent systematic review and meta-analysis indicated that approximately less than one-third (i.e., 31.1%) of pregnant women were admitted to ICU and 2.7% have died while about 11.3% of newborn infants admitted to ICU and 2.2% of them experienced perinatal death. However, no cases of transmission from mothers to their fetus were detected over the study period [11] . High body mass index and maternal age and preexisting comorbidities were found among the most common risk factors to manifest severe COVID-19. The rates of preterm birth were higher among COVID-19 infected pregnant women than non-infected pregnant women with COVID-19 [13] . Various systematic reviews indicated that pregnant and non-pregnant women shared almost similar symptoms of COVID-19 and the likelihood of vertical transmission from infected mothers to their neonates was rare [14 -15] . A study by Ferrazzi et al. found that only three out of 42 neonates were positively infected with COVID-19 who were born to mothers with COVID-19 in Italy [16] . Even though there are enormous studies on the effects of COVID-19 infection on pregnant women, newborns, and the possibility of vertical transmission, there is no strong and sufficient data to provide evidence regarding these effects [14] .

With this current COVID-19 outbreak, the current knowledge concerning the effects of COVID-19 on pregnant women and their neonates is still unclear and scarce.

Therefore, this study aims to investigate the COVID-19 clinical manifestations and J o u r n a l P r e -p r o o f outcomes of maternal and neonates as well as exploring the possibility of vertical transmission of COVID-19 from mothers to their new-borns.

This is a retrospective cohort and multicenter study of positively COVID-19 infected pregnant women who delivered at the designed three selected hospitals located in Riyadh city in Saudi Arabia during the period from March 2020 to November 2020. 

Data were collected from the available medical records in the respective hospitals using a standardized Data collection sheet on maternal and neonatal clinical outcomes  Neonatal characteristics including PCR result, days from birth to COVID-19 detection, sex, neonatal death, birth weight, GA at delivery, 1-min and 5-min APGAR scores, respiratory support, PCR result 1 st, and 2 nd sample, lab results, and mortality.

For confidentiality, the data will be assured that all information provided will be treated in strict confidentiality and will be used solely for research purposes. All forms will be stored in a locked file cabinet in a locked office and will be erased on completion of the research. To assure anonymity the name will not be written, or any identifying information in any part of the research. The study has been approved by the research committee in King Fahad Medical City.

This study utilized SPSS 24.0 software to perform all statistical analysis. All continuous variables were presented as a median and interquartile range (IQR) as appropriate. All categorical variables were presented as frequencies and percentages.

The current study has identified 288 pregnant women with confirmed COVID-19 infection from the three hospitals distributed as King Fahad Medical City (KFMC), Al-Yammamah hospital (AYH), and Imam Abdulrahman Al-Faisal hospital (AIAAFH). as indicated in Figure 1 . Table 1 ).

The majority of pregnant women were delivered (n = 204, 70.8%) and with single fetus (n = 200, 98%). Viginal delivery was prevalent among approximately less than two-thirds of delivered women (n = 131, 64.2%). The most common adverse pregnancy outcome was premature (n= 31, 15.5%), followed by fetal distress (n = 13 (6.5%), Preeclampsia (n = 4, 2.0%), and one pregnant woman died (Table 1 ). J o u r n a l P r e -p r o o f symptoms among pregnant women were cough (31.9%) and fever and dyspnea (12.5%), which is congruent with most previous research and reports [12, 14, 15, 17, 22, 23, 29, 32, 37, 38, 41] . A retrospective cohort study in the New York City hospital in the United States found that dry cough, fever, and myalgias at the presentation were among the most common COVID-19 symptoms among pregnant women [38] . A most recent systematic review and meta-analysis found that the most observed complaints by pregnant women were fever (76%; 95% C.I is [57% -90%]) and cough (38%; 95% C.I is [28% -47%]) [12] . Also it has been reported that fever, cough, and J o u r n a l P r e -p r o o f dyspnea were among the most common symptoms of COVID-19 at presentation plus fatigue, and myalgia [14, 15] . Those symptoms were also common among infected pregnant women in Kuwait [41] . Other less common symptoms were sore throat, fatigue, myalgia, malaise, diarrhea, and vomiting [12, 15, 38, 41] . However, a systematic review of sixty studies indicated that about 43.5 to 92.0% of pregnant women were asymptomatic [21, 34] . The current study indicates that the majority of pregnant women were hospitalized due to Covid-19 disease during their 3 rd trimester (i.e., median GA at presentation was 38 weeks), which consistent with the findings of most overseas studies [10, 12, 27, 30, 37, 38] . However, the study in Kuwait showed that most pregnant women were hospitalized at a median gestational age of 29 weeks in addition to some Chinese studies which showed that the average gestational age at presentation was 30 weeks [18, 41, 42] . The most prevalent comorbidity conditions were obesity (27.1%) and anemia (4.5%). The study conducted in the New York City hospital found obesity and mild intermittent asthma as the most prevalent comorbidity conditions of pregnant women [38] .

Maternal laboratory tests indicate that the majority of pregnant women had hemoglobin levels lower than 13.0. However, lymphopenia was observed among 43.8% of pregnant women. Neutropenia, thrombocytopenia, higher body temperature (i.e., > 38), and leukopenia were observed among 18.6%, 12.2%, 9.4%, and 6.6% of them, respectively. In addition, increased concentration of AST and ALT were observed among 10.8% and 4.2% among patients, respectively. Hemoglobin levels were in the normal range among the majority of pregnant women. The findings are consistent with previous research and reports but the prevalence of laboratory tests was variant [10, 12, 14, 15, 41, 44, 45] . More specifically, lymphopenia was common not only among pregnant women with COVID-19 infection but also among the J o u r n a l P r e -p r o o f general population with confirmed COVID-19 infection [34, 46, 47] . Moreover, more than two-thirds of pregnant women in the current study delivered, and only four of them had twin fetuses. Cesarean section and vaginal modes were observed as methods of delivery where the last mode being most prevalent among delivered women (64.2%). This finding is consistent with previous findings as these delivery methods were observed in previous research [12, 14, 15, 17, 22, 23, 29, 32, 37, 38, 41] . A recent systematic review and meta-analysis indicated that the prevalence of cesarean section was detected in several studies and ranged from 66.7% to 100% of pregnant women where the pooled percentage of cesarean section was 88% [12] . Another systematic review found that cesarean section was presented among 78.1% of pregnant women with confirmed COVID-19 infection [14] . In Wuhan Children's Hospital, Kuwait, and New York City Center hospital, cesarean section was carried out among 78.8%, 47.8%, and 44.4% of pregnant women, respectively [37, 38, 41] .

The most frequent adverse pregnancy outcomes and complications were premature (15.5%), fetal distress (6.5%), preeclampsia (2.0%), and one maternal death (0.5%) for which these complications had occurred among pregnant women who were in less than 37 weeks of gestational age. The current study is in line with previous findings that found that premature, fetal distress, preeclampsia, placenta praevia, uterine rupture, gestational diabetes, hypertension, fetal asphyxia, stillbirth, abortion, and maternal death were being among the broad adverse pregnancy outcomes [10, 12 -16, 18, 20-21, 34, 38, 41, 45, 48] .

Following maternal treatment, patients were mostly medicated with antibiotics, antivirals, and corticosteroid medications. Furthermore, a small proportion of pregnant women required respiratory support and admission to the ICU (3.8%) and

mostly they have developed symptoms of pneumonia and were between 28 to 36 J o u r n a l P r e -p r o o f weeks' gestational age. Almost all of them have been discharged from the hospital with 3 days median length of stay except one patient had died. Our findings are in line with previous research findings, which provide evidence of low ICU admission and very low mortality rates among pregnant women [10, 12 -15, 18, 21, 34, 38, 41, 45, 48] . A recent systematic review and meta-analysis revealed that the proportion of admission to ICU was 4% in several studies [12] . Likewise, the pooled percentage of admission to ICU among pregnant women was 13% [13] . Another systematic review found that 4.7% of pregnant women were required admission to the ICU [14] .

Mortality rates were extremely low as indicated in several studies and most studies did not report any deaths [12 -15, 41, 45, 49] . Recent studies have shown that the ICU admission and mortality rates among pregnant women are comparable with the general population infected with COVID-19 disease [26, 50] . Therefore, maternal COVID-19 clinical outcomes are almost similar to those among general individuals with confirmed COVID-19 infection [51] . Of 200 newborns included in the current study, there were 15.5% of them are born preterm and the median gestational age at delivery was 39 weeks. Similarly, a retrospective descriptive study in Kuwait and a prospective cohort study in the United Kingdom found that about 26.6% and 66% of newborns were preterm infants, respectively, which is higher than our findings [41, 50] . The pooled percentage of preterm babies was 23%, which higher than our proportion [12] . The median gestational age at delivery of 38 weeks in these studies [41, 50] . However, a systematic review shows that the average gestational age at delivery ranged from 28 to 41 weeks [14] . This study also shows that a small proportion of newborns had birth weights less than 2500 to 4000g, which congruent with previous studies [10, 12, 14, 15, 41, 44, 45] . Almost all neonates had 1-minute and 5-minute Apgar scores of higher than 5 meaning that almost all of them did not J o u r n a l P r e -p r o o f require assistance for establishing breathing at 1-minute and 5-minute of age [52] . We found almost similar results to those revealed in various studies for which these studies indicated that both 1-minute and 5-minute Apgar scores were 7 -9 and 8 -10, respectively [10, 14, 20, 36, 38, 41, 44, 45, 53, 54] . [23] . Some studies indicated that fever, pneumonia, lymphopenia, respiratory distress syndrome, low birth weight, and rapid heart rate were among the frequent neonatal complications who were born for mothers of confirmed COVID-19 infection [10, 23, 37, 55] . Meanwhile, another retrospective study conducted in Wuhan did not find any evidence of these neonatal complications [54] . The rate of neonatal admission to the ICU was somewhat high (43%) and the IUGR was 1.5% of neonates. There were no neonatal deaths and the median length of stay was 8 days but there were four cases of fetal deaths. A study in Italy showed that adverse neonatal outcomes were preterm birth (26%) as a result of worsening maternal COVID-19 symptoms and spontaneous labor [16] . A recent report in China showed that about 47% of all newborns were transferred to the NICU and there was one neonatal death due to severe neonatal asphyxia [26] . Moreover, a cohort study in the United States indicates that about 63.6% of neonates were transferred to the NICU and no neonatal death was observed [56] . The current study also finds that antibiotic medication was given to 31% of J o u r n a l P r e -p r o o f neonates and about 7% of neonates needed mechanical ventilation support but this was probably due to the neonatal complications of preterm delivery at lower than 37

weeks not due to COVID-19 infection [12] .

All alive newborns in this study were not infected with COVID-19 disease and we did not find any evidence of vertical transmission from mothers with confirmed COVID-19 infection to neonates. This finding is congruent with most previous studies that showed little evidence of possible vertical transmission [23, 27, 38] . A systematic review and meta-analysis show that the pooled percentage of infected neonates with COVID-19 disease was 6% indicate newborns are at low risk of infection [12] . In

Kuwait, only 2 out of 185 neonates got infected for infected mothers with COVID-19 [41] . Nevertheless, the current knowledge on vertical transmission of COVID-19 from mothers to their neonates in most review studies is inconclusive [12, 14, 15] .

Therefore, further studies are needed to provide strong evidence regarding vertical transmission potentials.

The current study adds further knowledge to the currently available evidence This study, however, is subject to some potential limitations. First, the lack of full medical records exhibited by the presence of some missing values limits our attempts to investigate some potential maternal and neonatal complications. Second, this is a descriptive study and thus we were not able to draw some inferences in terms of J o u r n a l P r e -p r o o f testing and comparing two groups. For example, testing whether there are significant differences in clinical outcomes among pregnant and non-pregnant with confirmed COVID-19 infection. The generalizability of this study should be interpreted with caution since the medical records had a loss of follow-up over the study period and the prevalence of disease may differ greatly according to the geographic regions especially in those with low disease prevalence due to heterogeneity in health conditions across regions and therefore the results may not be generable to all regions or medical centers. Therefore, further studies are needed to provide in-depth state of art of COVID-19 outcomes among maternal and neonates at the national level.

This is a multicenter study carried out in three different hospitals located in Riyadh, Saudi Arabia. This study revealed that the majority of pregnant women had mild or moderate disease symptoms. Nevertheless, this study did not find any evidence of possible vertical transmission of COVID-19 infection from mothers to their babies.

The findings of this study shed light on some important interventions and implications concerning improving the health systems and may insist on some policy interventions for disease prevention control strategies during this current pandemic.

Finally, this study may provide a baseline for further studies focusing on investigating long-term maternal and neonate's outcomes and possible vertical transmission of COVID-19 from mothers to their newborn babies.

World Health Organization

WHO. Rolling updates on coronavirus disease

Coronavirus disease update; events as they happen

What are the symptoms of COVID-19?

H1N1 2009 influenza virus infection during pregnancy in the USA

Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection

Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia

Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis

COVID-19 in pregnant women: A systematic review and meta-analysis

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and metaanalysis

Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal, and neonatal outcome: systematic review

Coronavirus disease 2019 (COVID-19): a systematic review of pregnancy and the possibility of vertical transmission

Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis

An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Archives of pathology & laboratory medicine

Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study

Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2

Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review

COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes, and vertical transmission

Clinical characteristics of 46 pregnant women with a SARS-CoV-2 infection in Washington State

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia

The relationship between status at presentation and outcomes among pregnant women with COVID-19

Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples

Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases

Analysis of pregnancy outcomes of pregnant women during the epidemic of new coronavirus pneumonia in Hubei

Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study

Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia

Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn

Clinical characteristics and risk assessment of newborns born to mothers with COVID-19

Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth

COVID-19 in pregnancy: risk of adverse neonatal outcomes

Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review

A 55-day-old female infant infected with 2019 novel coronavirus disease: presenting with pneumonia, liver injury, and heart damage

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China

COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Clinical characteristics of COVID-19 infection in newborns and pediatrics: a systematic review

Synthesis and systematic review of reported neonatal SARS-CoV-2 infections

Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait

A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance

Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis

Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy

Effects of severe acute respiratory syndrome coronavirus 2 infections on pregnant women and their infants

Laboratory Abnormalities in Pregnant Women with Novel Coronavirus Disease

Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia

Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: a national population-based cohort study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A proposal for a new method of evaluation of the newborn. Classic Papers in Critical Care

Maternal death due to COVID-19 disease

Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan

Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry

Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study

The authors would like to thanks the Research Centre, King Fahad Medical City, Riyadh, Saudi Arabia, for providing support in preparing this manuscript.J o u r n a l P r e -p r o o f

The authors have no conflicts of interest to declare